This Reflections Speaker Program is sponsored by Bristol Myers Squibb (BMS). This Program is for relapsed/refractory patients to learn more about multiple myeloma and Pomalyst from the personal experience of a patient and the expertise of a healthcare professional. THIS MEETING WILL NOT BE RECORDED.
This presentation will feature a Reflections Patient Speaker sharing their personal story with Pomalyst, as well as Dr. Michael Dugan from Indiana State University School of Medicine who will provide information about important topics like:
• Multiple myeloma review and key points
• An overview of Pomalyst
• Tips for patients talking with their healthcare team
• An overview of patient financial support services
Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Michael Dugan, MD., received his medical degree from Indiana University School of Medicine in Indianapolis, IN. He completed a residency in internal medicine at the Methodist Hospital of Indiana, and a fellowship in hematology/oncology at the University of Minnesota. Dr. Dugan is an attending physician at Indiana Blood & Marrow Transplantation in Indianapolis, IN. He has authored and coauthored papers for peer-reviewed medical journals. Dr. Dugan is a member of American Society for Blood and Marrow Transplantation, American Society of Hematology, and American Society of Clinical Oncology.
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
+1 800 709 1113
Support@healthtree.org
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.